A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder

Summary

This six-week study will evaluate the efficacy, safety and tolerability of GSK561679 compared to placebo in female subjects with major depressive disorder

Timeline

Start

2008-10-02

Primary completion

2010-06-18

Completion

2010-06-18

Publications

• Background GSK has concluded that it is not feasible to publish this study in a peer-reviewed scientific journal because the nature of the study is unlikely to be of interest to a journal. GSK is providing the attached study results summary with a conclusion.

Drugs

Indications